Celldex Therapeutics Inc (CLDX)
2.14
-0.13 -5.73%
NASDAQ
Nov 18, 16:35
Delayed 2m
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 4.45M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -3.80 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -49.83M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -2.09K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0% |
| Price and Valuation | |
| Market Cap | 34.52M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 6.392 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 0.3405 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -11.28M |
| Return on Equity (TTM) | Upgrade |
View All CLDX News
News
-
WireHeadlineTime (ET)
-
Globe Newswire11/18 08:01
-
Yahoo11/14 09:44
-
MT Newswires11/13 15:44
-
MT Newswires11/13 05:12
-
Yahoo11/12 09:25
-
SA Breaking News11/12 08:11
-
Globe Newswire11/12 08:01
-
Globe Newswire11/11 08:01
-
Globe Newswire11/08 07:30
-
Yahoo10/30 10:33
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 03/06/2020 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2019 |
| 03/06/2020 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2019 Release |
| 11/12/2019 | Earnings | Celldex Therapeutics Inc Third Quarter Earnings Results for 2019 |
| 08/07/2019 16:30 EDT | Misc | Celldex Therapeutics Inc Second Quarter Earnings Conference Call in 2019 |
| 08/07/2019 | Earnings | Celldex Therapeutics Inc Second Quarter Earnings in 2019 Release |
| 06/19/2019 09:00 EDT | Misc | Celldex Therapeutics Inc Annual General Meeting in 2018 |
| 05/07/2019 | Earnings | Celldex Therapeutics Inc First Quarter Earnings Results in 2019 |
| 03/07/2019 16:30 EST | Misc | Celldex Therapeutics Inc Fourth Quarter Earnings Conference Call in 2018 |
| 03/07/2019 | Earnings | Celldex Therapeutics Inc Fourth Quarter Earnings in 2018 Release |
| 03/07/2019 | Misc | Celldex Therapeutics Inc Annual Report in 2018 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: http://www.celldex.com
- Investor Relations URL: http://ir.celldex.com/index.cfm
- HQ State/Province: New Jersey
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Mar. 06, 2020
- Last Earnings Release: Nov. 12, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.14 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- CLDX Tweets Stocktwits
Advertisement
